why choose us

First received: November 30, 2023

Clinical Trial: Autologous TLPO Vaccine Basket

Study Status: Completed

Recruit Status: RECRUITING

Condition: Tumor, Solid

Study Type: INTERVENTIONAL


Official Title: A Prospective, Open-Label, All-Comers Phase IIa Trial of The Tumor Lysate, Particle Only (TLPO) Cancer Vaccine in Solid Tumor Malignancies

Brief Summary: The goal of this clinical trial is to learn about TLPO cancer vaccine in cases of solid tumor malignancies.The main objectives it aims to learn about are:What is the time to progression/recurrence of disease after vaccination with the autologous TLPO vaccine in multiple solid tumor malignancies?What is the overall survival after vaccination with the autologous TLPO vaccine in multiple solid tumor malignancies?What are the safety characteristics of autologous TLPO using standardized criteria (Common…

Read more